We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Custom Lentivirus Pseudotyped with Spike Glycoprotein from SARS-CoV-2
Product News

Custom Lentivirus Pseudotyped with Spike Glycoprotein from SARS-CoV-2

Custom Lentivirus Pseudotyped with Spike Glycoprotein from SARS-CoV-2
Product News

Custom Lentivirus Pseudotyped with Spike Glycoprotein from SARS-CoV-2


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Custom Lentivirus Pseudotyped with Spike Glycoprotein from SARS-CoV-2"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

AMSBIO has extended its COVID-19 research portfolio with the introduction of a service to provide custom lentivirus pseudotyped with spike glycoprotein from SARS-CoV-2 to help researchers identify potential targets for development of therapeutic drugs and vaccines.

Various research groups around the world have demonstrated that SARS-CoV-2 uses its spike glycoprotein S, a main target for neutralization antibody, to bind its receptor, and mediate membrane fusion and virus entry.

In response to widespread demand, AMSBIO has developed a custom service to provide ready-to-use in vitro and in vivo grade lentiviral particles pseudotyped with coronavirus S protein. Pseudotyping of lentivirus is available with wild type or mutant S proteins from a wide range of coronavirus species. In addition, AMSBIO can offer wide ranging customization options including addition of reporter genes for monitoring viral entry. This complete range of products are safe to be used in BSL-2 labs.

The AMSBIO lentiviral system is a novel gene delivery tool using lentivectors for gene expression or knockdown. Lentivirus can effectively transduce both dividing and non-dividing mammalian cells, and integrate into the host genome, allowing stable long-term, high-level gene expression both in vivo and in vitro

Advertisement